Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
11.23
-0.50 (-4.26%)
At close: Nov 10, 2026, 4:00 PM EST
11.23
0.00 (0.00%)
Pre-market: Nov 11, 2026, 7:49 AM EST
Cullinan Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
109
Market Cap
729.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 18.94M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 468.22M |
| Arbutus Biopharma | 181.72M |
| OmniAb | 40.21M |
| Janux Therapeutics | 23.29M |
| Prime Medicine | 4.07M |
| Attovia Therapeutics | 1.80M |
CGEM News
- 17 hours ago - Cullinan Therapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 20 hours ago - Cullinan Therapeutics reports Q3 EPS (74c), consensus (84c) - TheFly
- 1 day ago - Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 1 day ago - Cullinan Therapeutics Earnings release: Q3 2026 - Filings
- 1 day ago - Cullinan Therapeutics Quarterly report: Q3 2026 - Filings
- 1 day ago - Cullinan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 days ago - Cullinan announces data from Genrix Bio Phase 1b/2a study of velinotamig - TheFly
- 2 days ago - Velinotamig, a BCMAxCD3 T Cell Engager, Achieves Complete Renal Responses and Significantly Reduces Disease Activity in Systemic Lupus Erythematosus in Data Presented at ACR Convergence 2026 - GlobeNewsWire